Stocktoria
PolyPid Ltd. PYPD
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-06-26
PolyPid Ltd. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| R&D expense | $23.8M | $22.8M | $16.1M | $28.0M | $30.6M | $17.0M | $14.1M |
| Operating income | -$33.0M | -$28.0M | -$22.9M | -$38.9M | -$43.1M | -$26.3M | -$18.6M |
| Income tax | $5,000 | $42,000 | $69,000 | $129,000 | — | — | — |
| Net income | -$34.2M | -$29.0M | -$23.9M | -$39.6M | -$42.6M | -$36.9M | -$6.9M |
| EPS (diluted) | $2.09 | $4.91 | $16.93 | $61.09 | $68.27 | $4.48 | $23.69 |
| Operating cash flow | -$27.9M | -$22.0M | -$17.2M | -$34.3M | -$32.4M | -$21.6M | -$17.4M |
| Free cash flow | -$28.1M | -$22.0M | -$17.4M | -$36.1M | -$35.0M | -$22.4M | -$18.2M |
| Cash & equivalents | $6.4M | $15.6M | $5.3M | $8.6M | $9.8M | $4.3M | $3.9M |
| Total assets | $22.3M | $25.2M | $15.4M | $26.0M | $44.2M | $75.8M | $33.8M |
| Shareholders' equity | $11.0M | $7.7M | -$2.1M | $5.8M | $36.0M | $72.8M | -$87.6M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| EPS growth | -57.4% | -71.0% | -72.3% | -10.5% | +1423.9% | -81.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.